Literature DB >> 2544507

Classical and cellular (atypical) congenital mesoblastic nephroma: a clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study.

G Pettinato1, J C Manivel, M R Wick, L P Dehner.   

Abstract

Sixteen cases of congenital mesoblastic nephroma (CMN) were studied. The tumors showed variable patterns of growth, degrees of cellularity, and mitotic activity. Six tumors had the classical pattern of CMN, seven were of the cellular or atypical variant and three showed combined features. The mean ages at presentation were 16 days, 5.3 months, and 2.3 months, respectively. Average size and weight were 5.1 cm and 94 g for classical CMN, 9.1 cm and 620 g for cellular CMN and 10.5 cm and 150 g for combined tumors. Cyst formation, hemorrhage and necrosis were confined to cellular CMNs and to cellular areas of combined CMNs. Mitotic activity ranged from 0 to 1/10 high-power fields (HPFs) in classical tumors to 25 to 30/10 HPFs in cellular tumors. Clear cell sarcoma-like areas were observed in three neoplasms. In ten cases there was invasion of perirenal fat; in one case each, invasion of the psoas muscle, renal vein wall, and renal vein lumen was observed. Ultrastructural and immunohistochemical studies showed features consistent with myofibroblastic differentiation. Flow cytometric analysis revealed euploidy in one classic CMN, one cellular CMN and in classic areas of a combined CMN; cellular areas of the latter tumor were aneuploid. All patients with follow-up were alive without evidence of disease after a mean period of 5 years following nephrectomy alone. No correlation was observed between the pathologic features assessed and the biologic behavior of these neoplasms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544507     DOI: 10.1016/0046-8177(89)90156-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

Review 1.  renal tumors and tumor-like lesions in pediatric patients.

Authors:  J M Kissane; L P Dehner
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714

2.  Primary renal sclerosing epithelioid fibrosarcoma: report of 2 cases with EWSR1-CREB3L1 gene fusion.

Authors:  Pedram Argani; Jack R Lewin; Pamela Edmonds; George J Netto; Carlos Prieto-Granada; Lei Zhang; Achim A Jungbluth; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2015-03       Impact factor: 6.394

Review 3.  [Rare childhood kidney tumors].

Authors:  C Vokuhl
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

4.  Unusual morphology in mesoblastic nephroma.

Authors:  Ranjana Bandyopadhyay; Uttara Chatterjee; Santosh K Mondal; Sugato Banerjee; Uday S Chatterjee
Journal:  Pediatr Surg Int       Date:  2008-11-07       Impact factor: 1.827

5.  Chromosome aberrations in mesoblastic nephroma.

Authors:  D E Schofield; E J Yunis; J A Fletcher
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  Congenital mesoblastic nephroma: possible prognostic and management value of assessing DNA content.

Authors:  J C Barrantes; C Toyn; K R Muir; S E Parkes; F Raafat; A H Cameron; H B Marsden; J R Mann
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

7.  Antenatally diagnosed kidney tumor: Answers.

Authors:  Wiebke Solass; Hyunkyu Shin; Cristian Urla; Andreas Schmidt
Journal:  Pediatr Nephrol       Date:  2020-12-09       Impact factor: 3.714

8.  Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma.

Authors:  Li Lei; Bradley A Stohr; Stacey Berry; Christina M Lockwood; Jessica L Davis; Erin R Rudzinski; Christian A Kunder
Journal:  Pract Lab Med       Date:  2020-05-16

9.  A case of fetal congenital mesoblastic nephroma with oligohydramnios.

Authors:  Cheol Hong Kim; Yoon Ha Kim; Moon Kyoung Cho; Ki Min Kim; Jin A Ha; Eun Hyun Joo; Seok Mo Kim; Tae-Bok Song
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

10.  Growing Renal Mass: Lessons Learned on the Road From an Atypical Presentation to Successful Therapy.

Authors:  Eliza Lamin; Dana A Weiss; Kassa Darge; Fumiko Dekio; Douglas A Canning
Journal:  Urol Case Rep       Date:  2015-06-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.